Primary radiotherapy for optic nerve sheath meningioma

Seminars in Ophthalmology

Volumn 19, Issue 3-4, 2004, Pages 130-140

  Melian, Edward ^a   Jay, Walter M ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Conformal radiotherapy; Optic nerve sheath meningioma

Indexed keywords

CANCER RADIOTHERAPY; HUMAN; MEDICAL TECHNOLOGY; MENINGIOMA; NERVE SHEATH TUMOR; OPTIC NERVE TUMOR; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; OPTIC NERVE NEOPLASMS;

EID: 11844259989     PISSN: 08820538     EISSN: None     Source Type: Journal    
DOI: 10.1080/08820530490884227     Document Type: Review

References (86)

1. Grunberg SM, Weiss MH, Spitz IM et al. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg. 1991;74:861-866.
2. Grunberg SM, Rankin C, Townsend J. Phase III randomized placebo-controlled study of mifepristone (RU) for the treatment of unresectable menigioma. Proc of Amer Soc Clin Onc. 2001;20:56a.
3. Grunberg SM. Role of antiprogestational therapy for meningiomas. Human Reproduction 1994;9:202-207.
4. Jaaskelainen J, Laasonen E, Karkkainen J et al. Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate. Acta Neuroch. 1986;80:35-41.
5. Schrell UM, Rittig MG, Anders M et al. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea. J Neurosurg. 1997;86:840-844.
6. Simpson D. The recurrence of intracranial meningioma after surgical treatment. J Neurol Neurosurg Pysch. 1957;20:22-39.
7. Mirimanoff RO, Dosoretz DE, Linggodd RM et al. Meningioma: Analysis of recurrence and progression following neurosurgical resection. J of Neurosurg. 1985;62:18-24.
8. Dutton JJ. Optic nerve sheath meningiomas. Surv Ophthamol. 1992;37:167-183.
9. Wright JE, McNab AA, McDonald WI. Primary optic nerve sheath meningioma. Br J of Ophthalmol. 1989;73:960-966.
10. Mathiesen T, Lindquist C, Kihlstrom L et al. Recurrence of cranial base meningiomas. Neurosurg. 1996;39(1):2-9.
11. Ebers GC, Girvin JP, Canny CB. A "possible" optic nerve sheath meningioma. Arch Neurol. 1980;37:781-783.
12. Mark LE, Kennerdell JS, Maroon JC. Microsurgical removal of a primary intraorbital meningioma. Am J Ophthalmol. 1978;86(5):704-709.
13. Capo H, Kupersmith MJ. Efficacy and complications of radiotherapy of anterior visual pathway tumors. Neuro Clinics. 1991;9(1):179-202.
14. Eggers H, Jakobiec FA, Jones IA. Tumors of the optic nerve. Documenta Ophthalmol. 1976;41(1):43-128.
15. Sarkies NJC. Optic nerve sheath meningioma: Diagnostic features and therapeutic alternatives. Eye 1987;1:597-602.
16. Cristante L. Surgical treatment of meningiomas of the orbit and optic canal: A retrospective study with particular attention to the visual outcome. Acta Neurochir. 1994;126:27-32.
17. Kuroda R, Nakatani J, Yorimae A et al. Clinical experience of intraorbital optic nerve sheath meningiomas. Neurol Med Chir. 1990;30:468-475.
18. Mourits MP, Berkelbach van der Sprenkel JW. Orbital meningioma, the Utrecht experience. Orbit. 2001;20(1):25-33.
19. Whittaker CK. Indications for removal of optic nerve sheath meningioma. AJNR 1997;18:396-397.
20. Cantore WA. Neural orbital tumors. Curr Opin Ophthalmol. 2000;11(5):367-371.
21. Ortiz O, Schochet SS, Kotzan JM. Meningioma of the optic nerve sheath. AJNR 1996;17:901-906.
22. King D, Chang C, Pool J. Radiotherapy in the management of meningiomas. Acta Radiol. 1966:5:2.
23. Rubenstein LJ. Tumors of the Central Nervous System. Armed Forces Institute of Pathology 1972;169-189.
24. Wara WM, Sheline GE, Newman H et al. Radiation therapy of meningiomas. Am J Roentgenol Radium Ther Nucl Med. 1975;123:453-458.
25. Barbara NM, Gutin PH, Wilson CB et al. Radiation therapy in the treatment of partially resected meningiomas. Neurosurg. 1987;20:4:525-528.
26. Glaholom J, Bloom HJG, Crow JH. The role of radiotherapy in the management of intracranial meningiomas: The Royal Marsden Hospital experience with 186 patients. Int J of Radiat Oncol Biol Phys. 1990;18(4):755-761.
27. Mirabell R, Linggood RM, de la Monte SM. The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neurooncol. 1992;13:157-164.
28. Solan MJ, Kramer S. The role of radiotherapy in the management of intracranial meningiomas. Int J Radiat Oncol Biol Phys. 1985;11:675-677.
29. Taylor BW, Marcus RB, Friedman WA et al. Int J Radiat Oncol Biol Phys. 1988 15:299-304.
30. Condra JS, Buatti JM, Mendenhall WM. Benign meningiomas: Primary treatment selection affects survival. Int J Radiat Oncol Biol Phys. 1997;39:427-436.
31. Goldsmith BJ, Wara WM, Wilson CB et al. Postoperative radiotherapy for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J of Neurosurg. 1994;80:195-201.
32. Mesic JB, Hanks GE, Doggertt RS. The value of radiation therapy as an adjuvant to surgery in intracranial meningiomas. Am J of Clin Oncol. 1986;9(4):337-340.
33. Akeyson EW, McCutcheon IE. Management of benign and aggressive intracranial meningiomas. Oncol. 1996;10(5):747-760. Kennerdell JS, Maroon JC, Malton M. The management of optic nerve sheath meningiomas. Am J of Ophthalmol. 1988;106(4):450-457.
34. Akeyson EW, McCutcheon IE. Management of benign and aggressive intracranial meningiomas. Oncol. 1996;10(5):747-760. Kennerdell JS, Maroon JC, Malton M. The management of optic nerve sheath meningiomas. Am J of Ophthalmol. 1988;106(4):450-457.
35. Wilson CB. Meningiomas: Genetics, maligancy, and the role of radiation in induction and treatment: The Richard C Schneider Lecture. J of Neurosurg. 1994;81:666-675.
36. Carella RJ, Ransohoff J, Newell J. Role of radiotherapy in the management of meningioma Neurosurg 1982;10(3):332-339.
37. Marie JP, Caudry M, Guerin J. Fractionated radiation therapy in the treatment of intracranial meningiomas: Local control, functional efficacy, and tolerance in 91 patients. Int J Radiat Oncol Biol Phys. 1995;33(2):315-321.
38. Kupersmith MJ, Warren FA, Newell J et al. Irradiation of meningiomas of the intracranial anterior visual pathways. Ann Neurol. 1987;21:131-137.
39. Delfini R, Missori P, Taratino R et al. Primary benign tumors of the orbital cavity: Comparative data in a series of patients with optic nerve glioma, sheath meningioma, or neurinoma. Surg Neurol. 1996;45:147-154.
40. Dutton JJ. Optic nerve gliomas and meningiomas. Neuroophthalmol. 1991;9(1):163-177.
41. Leber KA, Bergloff J, Pendl G. Dose response tolerance of the visual pathways and the cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg. 1998;88:43-50.
42. Marks JE, Baglan RJ, Prassad SC et al. Cerebral Radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume. Int J of Radiat Oncol Biol Phys. 1981;7:243-249.
43. Sheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury. Int J of Radiat Oncol Biol Phys. 1980;6(9):1215-1228.
44. Stelzer KJ. Acute and long-term complications of therapeutic radiation for skull base tumors. Neurosurg Clin of NA 2000;11:4:597-604.
45. Parsons JT, Bova FJ, Fitzgerald CR et al. Radiation optic neuropathy after megavoltage external beam irradiation: Analysis of time dose factors. Int J Radiat Oncol Biol Phys. 1994;30:755-763.
46. Brada M, Rajan B, Traish D et al. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clinical Endocrinology 1993;38:571-578.
47. Breen P, Flickinger JC, Kondziolka D et al. Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control. J Neurosurg. 1998;89:933-938.
48. McCord M, Buatti JM, Fennell EM et al. Radiotherapy for pituitary adenoma: Long-term outcome and sequelae. Int J Radiat Oncol Biol Phys. 1997;39(2):437-444.
49. Flickinger JC, Kondziolka D, Maitz AH et al. Gamma knife radiosurgery of imaging-diagnosed intracranial meningioma. Int J Radiol Oncol Biol Phys. 2003;56(3):801-806.
50. Pollock BE, Stafford SL, Link MJ. Gamma knife radiosurgery for skull base meningiomas. Neurosurgical Clinics of North America 2000;11(4):659-666.
51. Spiegelmann R, Nissim O, Menhel J et al. Linear accelerator radiosurgery for meningiomas in and around the cavernous sinus. Neurosurg. 2002;51(6):1373-1380.
52. Stafford SL, Pollock BE, Foote RL et al. Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurg. 2001;49(5):1029-1038.
53. Leber KA, Bergloff J, Pendl G. Dose response tolerance of the visual pathways and the cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg. 1998;88:43-50.
54. Ove R, Kelman S, Amin PP et al. Preservation of visual fields after perisellar gamma-knife radiosurgery. Int J Cancer 2000;90:343-350.
55. Tischler RB, Loeffler JS, Lunsford LD et al. Tolerance of the cranial nerves of the cavernous sinus to radiosurgery. Int J of Radiol Oncol Biol Phys. 1993;27:215-221.
56. Ganz JC, Schrottner O, Pendl G. Radiation-induced edema after gamma knife treatment for meningiomas. Stereotactic & Functional Neurosurg. 66 Suppl. 1996;1:129-133.
57. Singh VP, Kansal S, Vaishya S et al. Early complication following gamma knife radiosurgery for intracranial meningiomas. J Neurosurg. 2000;93:57-61.
58. Klink DF, Miller NR, Williams J. Preservation of vision 2 years after stereotactic radiosurgery for a presumed optic nerve sheath meningioma. J of Neuro Ophthalmol. 1998;18(2):117-120.
59. Eng TY, Albright NW, Kuwahara G et al. Precision radiotherapy for optic nerve sheath meningiomas. Int J Radiol Oncol Biol Phys. 1992;22:1093-1098.
60. Kooy HM, Dunbar SF, Tarbell NJ et al. Adaptation and verification of the relocatable Gill-Thomas-Cosman frame in stereotactic radiotherapy. Int J of Radiat Oncol Biol Phys. 1994;30(3):685-691.
61. Cohn EM. Optic nerve sheath meningioma: Neuroradiological findings. J Clin Neuro-ophthamol. 1983;3:85-89.
62. Johns TT, Citrin CM, Black J et al. CT evaluation of perineural orbital lesions: Evaluation of the "tram-track" sign. Am J of Neuro Rad. 1984;5:587-590.
63. Lloyd GS. Primary orbital meningioma: A review of 41 patients investigated radiologically. Clin Radiol. 1982;33:181-187.
64. Sibony PA, Krauss HR, Kennerdell JA et al. Optic nerve sheath meningiomas. Ophthalmol. 1984;91(11):1313-1326.
65. Lindblom B, Truwit CL, Hoyt WF. Optic nerve sheath meningiomas: Definition of intraorbital, intracanalicular, and intracranial components with magnetic resonance imaging. Ophthamol. 1992;99(4):560-566.
66. Mafee MF, Goodwin J, Dorodi S. Optic nerve sheath meningiomas: Role of MR imaging. Imaging in Ophthamology II in Radiologic Clin of North America 1999;37(1):37-58.
67. Zimmerman CF, Schatz NJ, Glaser JS. Magnetic resonance imaging of optic nerve meningiomas: Enhancement with gadolinium-DTPA. Ophthalmol. 1990;97(5):585-591.
68. Karlsson UL, Leibel S, Wallner K et al. Ch 23 Brain in Principles and Practice of Radiation Oncology. JB Lippincott Co., Philadelphia, 1992.
69. Levin VA, Gutin PH, Leibel S. Neoplasms of the central nervous system in Cancer Principles and Practice of Oncology, edited by Devita VT, Hellman S, Rosenberg SA. JB Lipponcott Co., Philadelphia, 1993.
70. Kondziolka D, Levy EI, Niranjan A et al. Long-term outcomes after meningioma radiosurgery: physician and patient perspectives. J of Neurosurg. 1999;91(1):44-50.
71. st International Novalis Circle Meeting, Barcelona, Spain, June 14-15, 2002.
72. Smith JL, Vuksanovic MM, Yates BM et al. Radiation therapy for primary optic nerve meningiomas. J Clin Neuro-Ophthalmol. 1981;1:85-99.
73. Kennerdell JS, Maroon JC, Malton M. The management of optic nerve sheath meningiomas. Am J of Ophthalmol. 1988;106(4):450-457.
74. Fayaz I, Gentili F, Mackenzie IR. Optic nerve sheath meningioma. J Neurol Neurosurg Psych. 1999;67(3):408.
75. Yuceer N, Ergdogan A, Ziya H. Primary optic nerve sheath meningiomas. J of Neurol Sci. 1994;38:1555-1559.
76. Turbin RE, Thompson CR, Kennerdell JS et al. Ophthalmol. 2002;109:890-900.
77. Fineman MS, Ausburger JJ, Lee AG. A new approach to an old problem. Surv of Ophthamol. 1999;43(6):519-524.
78. Lee AG, Woo SY, Miller NR et al. Improvement in visual function in an eye with a presumed optic nerve sheath meningioma after treatment with three-dimensional conformal radiation therapy. J of Neuro Ophthal. 1996;16(4):247-251.
79. Moyer PD, Golnik KC, Breneman J. Treatment of optic nerve sheath meningioma with three dimensional conformal radiation. Am J of Ophthalmol. 2000;129(5):694-696.
80. Pitz S, Becker G, Schiefer U et al. Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative. Br J Ophthalmol. 2002;86:1265-1268.
81. Liu JK, Forman S, Hershewe GL et al. Optic nerve sheath meningiomas: Visual improvement after stereotactic. Radiother Neurosurg. 2002;50(5):950-956.
82. Andrews DW, Farooqan R, Yang BP et al. Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: Preliminary observations of 33 optic nerve in 30 patients with historical comparison to observation, with or without prior surgery. Neurosurg. 2002;51:890-904.
83. Narayan S, Cornblath WT, Sandler HM et al. Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meninigioma. 2003;56:2:537-543.
84. Becker G, Jeremic B, Pitz S et al. Stereotactic fractionated radiotherapy in patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys. 2002;54:5: 1422-1429.
85. Hollenhorst Sr RW, Hollenhorst Jr RW, MacCarty CS. Visual prognosis of optic nerve sheath meningiomas producing shunt vessels on the optic cisk: The hoyt spenser syndrome. Tr Am Ophthal Soc. 1977;75:141-163.
86. Emami B, Lyman J, Brown A et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109.